Current status on the clinical usefulness of apheresis in patients with inflammatory bowel disease

Δείτε το αρχείο http://www.annalsgastro.gr/index.php/annalsgastro/article/view/199  
Φορέας Ελληνική Γαστροεντερολογική Εταιρία
Συλλογή Annals of Gastroenterology Current status on the clinical usefulness of apheresis in patients with inflammatory bowel disease
Επιμέρους συλλογή Current views
ΠεριγραφήSUMMARY In this review the current aspects concerning the application of leukocytapheresis in patients with inflammatory bowel disease are briefly discussed. Leukocytapheresis has already been applied in patients suffering mainly from diseases affecting the immunological balance. The procedure has recently been tried in patients with ulcerative colitis and Crohn’s disease as well, with promising results. Leukocytapheresis is gaining in interest as a therapeutic procedure of the near future, because it removes - in a short time- a number of immunologically active cells, which are well known to actively participate in the inflammatory cascade, leading to tissue damage. However, further studies are needed in order to better clarify the role of leukocytapheresis in the maintenance treatment of patients with inflammatory bowel disease, either alone, or in combination with drugs of known efficacy in IBD. Key words: Apheresis, Leucocytapheresis, Inflammatory bowel disease, Ulcerative colitis, Crohn’s disease
Δημιουργός P. Cherakakis, J.K. Triantafillidis,
ΕκδότηςAnnals of Gastroenterology
Ημερομηνία2007-03-19
Μορφότυποςapplication/pdf
ΠηγήAnnals of Gastroenterology; Volume 16, No 2 (2003)